Abstract
NMDA receptor hypofunction (NRH) has been implicated in the pathophysiology of schizophrenia because of the ability of phencyclidine (PCP), a noncompetitive NMDA receptor antagonist, to precipitate a schizophreniform psychosis. The possible role that NRH plays in the pathophysiology of schizophrenia stimulated characterization of behaviors elicited by PCP and its analogues. For example, MK-801 (dizocilpine), a noncompetitive NMDA receptor antagonist that binds with higher affinity to the same hydrophobic channel domain as PCP, raises the threshold voltage required for the electrical precipitation of tonic hindlimb extension in mice. This ability of MK-801 is significantly reduced following stress. We showed that an exogenously administered glycine prodrug (i.e., milacemide) was able to potentiate MK-801's antiseizure efficacy in unstressed mice and restore MK-801's antiseizure efficacy in stressed animals. d-Serine may serve as an endogenous agonist for the obligatory glycine co-agonist site on the NMDA receptor complex. Orally administered d-serine has been studied clinically as an adjuvant therapeutic intervention in schizophrenia. Thus, we were surprised at its inability to potentiate MK-801's antiseizure efficacy in either ...Continue Reading
References
Oct 1, 1992·Pharmacology, Biochemistry, and Behavior·D O NorrisS I Deutsch
Oct 1, 1991·The American Journal of Psychiatry·D C Javitt, S R Zukin
Feb 1, 1989·Clinical Neuropharmacology·S I DeutschJ M Morihisa
Apr 25, 1995·Proceedings of the National Academy of Sciences of the United States of America·M J SchellS H Snyder
Aug 1, 1994·Brain Research·K HoriikeT Maeda
Feb 1, 1994·Neurochemical Research·D O NorrisS I Deutsch
Apr 1, 1997·Proceedings of the National Academy of Sciences of the United States of America·M J EliassonS H Snyder
Jun 9, 1997·Biochemical and Biophysical Research Communications·D S Dunlop, A Neidle
Oct 23, 1997·Clinical Neuropharmacology·S I DeutschJ Mastropaolo
Dec 4, 1998·Biological Psychiatry·G TsaiJ T Coyle
Feb 11, 1999·Pharmacology, Biochemistry, and Behavior·S I DeutschJ Mastropaolo
Nov 11, 1999·Proceedings of the National Academy of Sciences of the United States of America·H WoloskerS H Snyder
Jun 23, 2000·Neuroscience Letters·J NakauchiY Kanai
Nov 9, 2005·Archives of General Psychiatry·Hsien-Yuan LaneGuochuan E Tsai
Citations
Aug 16, 2008·Psychopharmacology·Alessandro GozziAngelo Bifone
Feb 18, 2009·Drugs & Aging·Monique P Curran, Jennifer S Orman
Aug 5, 2008·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Pin-Yu PereraStephen I Deutsch
Aug 26, 2020·British Journal of Pharmacology·Jing WangKeWei Wang